Enliven Therapeutics, Inc. (ELVN)

Typically moves ±4.29% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-08-13 APPROXIMATE

Across 21 earnings reports since May 07, 2020, Enliven Therapeutics, Inc. (ELVN) has a clear post-earnings pattern. It moves ±4.29% on average after reporting and finishes higher 57.1% of the time. Its largest post-earnings gain was +9.72% (Mar 15, 2022) and its largest decline was -19.01% (Mar 05, 2021). The next earnings report is predicted for 2026-08-13 (approximate).

Earnings reactions

How ELVN moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.29%

Positive %

57.1%

Negative %

42.9%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 07, 2026	☽ POST	+1.19%	open_in_new
Mar 03, 2026	☽ POST	+4.28%	open_in_new
Nov 12, 2025	☽ POST	-0.15%	open_in_new
Aug 13, 2025	☽ POST	-1.08%	open_in_new
May 14, 2025	☽ POST	-10.41%	open_in_new
Mar 13, 2025	☽ POST	+2.22%	open_in_new
Nov 13, 2024	☽ POST	-3.41%	open_in_new
Aug 13, 2024	☽ POST	+1.3%	open_in_new
May 14, 2024	☽ POST	+0.54%	open_in_new
Mar 14, 2024	☽ POST	+3.73%	open_in_new
Nov 09, 2023	☽ POST	-1.47%	open_in_new
Aug 10, 2023	☽ POST	+0.11%	open_in_new
May 11, 2023	☽ POST	+1.57%	open_in_new
Mar 15, 2022	☀ PRE	+9.72%	open_in_new
Nov 09, 2021	☀ PRE	+5.39%	open_in_new
Aug 06, 2021	☀ PRE	-1.53%	open_in_new
May 11, 2021	☀ PRE	+7.34%	open_in_new
Mar 05, 2021	☀ PRE	-19.01%	open_in_new
Nov 05, 2020	☀ PRE	-2.1%	open_in_new
Aug 14, 2020	☀ PRE	+1.98%	open_in_new
May 07, 2020	☀ PRE	-11.5%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.29%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 16 →

Funds holding

$250323792

Total value held

Buying

14 added · 1 reduced

Blackrock, Inc.

$144440514 +1.98%

State Street Corp

$42771355 +3.63%

Morgan Stanley

$20328037 +25.92%

Goldman Sachs Group Inc

$18546108 +99.45%

Northern Trust Corp

$14594788 +5.70%

SEC Filing Types

description SCHEDULE 13G/A

14 chevron_right

description SC 13G

14 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260721	open_in_new SEC.gov
4	20260721	open_in_new SEC.gov
144	20260717	open_in_new SEC.gov
4	20260708	open_in_new SEC.gov
4	20260624	open_in_new SEC.gov
SCHEDULE 13D/A	20260624	open_in_new SEC.gov
144	20260622	open_in_new SEC.gov
144	20260622	open_in_new SEC.gov
144	20260622	open_in_new SEC.gov
4	20260622	open_in_new SEC.gov

Frequently asked about ELVN earnings

When does Enliven Therapeutics, Inc. report earnings next? expand_more

Enliven Therapeutics, Inc. (ELVN)'s next earnings date is approximate for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does ELVN stock move after earnings? expand_more

Over 21 reports, ELVN has moved an average of ±4.29% the session after earnings, closing higher 57.1% of the time.

What was ELVN's biggest post-earnings move? expand_more

ELVN's largest post-earnings gain on record was +9.72% on Mar 15, 2022, and its largest decline was -19.01% on Mar 05, 2021.

Where can I find Enliven Therapeutics, Inc.'s SEC filings? expand_more

All of Enliven Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.